Programme Outline
GREAT ILANGA | ILANGA SUITE 1-3 | ILANGA SUITE 4-5 | |
Morning | Arrival in Durban (possible site visit to SANBS office in Mount Edgecombe en route to Southern Sun Elangeni – dependent on flight arrival time) | ||
11h00-16h00 | Registration open at Southern Sun Elangeni Conference Centre | ||
12h30-13h30 | Lunch | ||
13h30-15h00 | Workshop 1: Building resilience and strategies to prevent burn-out. (Hemari Bonthuys) |
Workshop 2: Communicating with impact. (Brett Anderson-Terry) |
Workshop 3: The future of digital marketing. (George Wyngaardt) |
15h00-15h30 | Tea break | ||
15h30-17h00 | Workshop 1 (repeat): Building resilience and strategies to prevent burn-out. (Hemari Bonthuys) |
Workshop 2 (repeat): Communicating with impact. (Brett Anderson-Terry) |
Workshop 3 (repeat): The future of digital marketing. (George Wyngaardt) |
17h00-19h00 | Registration open at Durban ICC | ||
17h45-18h00 | Buses depart for Durban ICC | ||
18h00-21h00 | Official opening of exhibition & welcome reception MC: Ravi Reddy (Exhibition Hall 2, Durban ICC) |
GREAT ILANGA | ILANGA SUITE 1-3 | ILANGA SUITE 4-5 | |
08h00-17h00 | Registration open | ||
08h15-08h45 | Buses depart for Durban ICC from SS Elangeni | ||
09h00-10h30 | OPENING PLENARY SESSION Hall 1 (Chairs: Marion Vermeulen & Wendy Sykes) |
||
09h00-09h10 | Introduction & welcome Marion Vermeulen, President SASBT Wendy Sykes, Chair – Organising Committee |
||
09h10-09h20 | Scientific program and keeping safe. (Greg Bellairs) |
||
09h20-09h55 | The New Normal: what did we learn from the COVID-19 pandemic and what changes should blood services internationally adapt to and adopt for a sustainable future? (Graham Sher) |
||
09h55-10h30 | Blood donors, registries and repositories for transfusion research. (Mars Stone) |
||
10h30-11h00 | Tea break | ||
11h00-12h30 | PLENARY 2 Hall 1 (Chairs: Ravi Reddy & Solomuzi Ncgobo) |
||
11h00-11h30 | Fecal Microbiota Transplantation – a status update from Europe’s largest FMT centre. (Christian Erikstrup) |
||
11h30-12h00 | Implementation of a Patient Blood Management program at Groote Schuur Hospital. (Vernon Louw) |
||
12h00-12h30 | PROTECT Trial – using the blood services as a platform for clinical research. (Karin van den Berg / Marion Vermeulen) |
||
12h30-14h00 | Lunch Break (Exhibition Hall 2) | ||
14h00-15h30 | COVID-19 – Insights and perspectives Room 21 (Chairs: Carmen Addinall & Greg Bellairs) |
Haemovigilance Room 11 (Chairs: Caroline Hilton & Meridah Mwase) |
Stem cells and alternative therapies Room 12 (Chairs: Lavendri Govender & Tanya Glatt) |
14h00-14h15 | Blood donors and COVID-19 surveillance. (Christian Erikstrup) |
The prevalence of methicillin-resistant staphylococcus aureus in blood product hampers at the South African National Blood Service. (Varsha Seoraj) |
Allogeneic platelet lysates for regenerative medicine. (Thierry Burnouf) |
14h15-14h30 | Brachial artery pseudoaneurysm, a rare complication of blood donation, at the Western Cape Blood Service, South Africa. (Shaldine Sutton) |
||
14h30-14h45 | Self-reported COVID-like symptoms in blood donors in January 2021. (Ronel Swanevelder) |
An analysis of donor adverse reactions following the alignment of SANBS policies to the AABB’s severity grading tool of blood donor adverse events. (Antoinette Porter) | Granulocyte transfusions successful in improving neutrophil counts in patients with severe neutropenia. (Tanya Glatt) |
14h45-15h00 | SARS-CoV-2 seroprevalence study among staff at the Western Cape Blood Service. (Nadia Pietersen) |
The effect of reduced deferral periods on the donor deferral rate at the Western Cape Blood Service, South Africa. (Caroline Hilton) | SANBS-produced human platelet lysate supports the proliferation of haematopoietic stem cells. (Riana Cockeran) |
15h00-15h15 | Seroprevalence of SARS-CoV-2 antibodies among blood donors in all provinces of South Africa during different time points in 2021. (Charl Coleman) |
Clinicians’ awareness of the South African blood service haemovigilance program, an empirical evidence based on survey conducted in 2020. (Francis Ledwaba) |
Collection efficiency of CD34 haematopoietic progenitor stem cells in clinical apheresis collections. (Thabo Gcayiya) |
15h15-15h30 | Measuring COVID-19 vaccine effectiveness in blood donors. (Eduard Grebe) |
The South African lookback programme – do South African doctors appreciate the importance of this surveillance? (Natasha von Meyer) |
An analysis of racial distribution amongst unrelated potential stem cell transplant patients and factors that play a role in finding a matched donor – a 3-year retrospective study. (Zahier Isaacs) |
15h30-16h00 | Tea break (Exhibition Hall 2) | ||
16h00-17h30 | Information service delivery Room 11 (Chairs: Jacques Breslaw & Ronel Swanevelder) |
What’s new in quality management systems? Room 12 (Chair: Shaldine Sutton & Michael Lennards) |
Recruiting and retaining blood donors Room 21 (Chairs: Marike Gevers & Isaac Mafisa) |
16h00-16h15 | Harnessing the disruptions: exploring relevant technological and digital innovations that offer meaningful opportunities for blood service sustainability. (Graham Sher) |
Quality control testing on leukodepleted blood products. (Hellen Sarela) |
Adjusting high school blood drive scheduling to increase collections and improve customer service in the Eastern Cape zone of SANBS. (Derryn Fuller) |
16h15-16h30 | ISO 15189 implementation in the South African National Blood Service. (Feroza Tree) |
Retrospective evaluation of blood collection on the Limpopo branch of the South African National Blood Service. (Bookie Dube) |
|
16h30-16h45 | Remote working in the face of the pandemic. (Nico van der Walt) |
Establishment of a stable microbiology proficiency testing matrix in transfusion microbiology. (Xoliswa Mpumlwana) | Offering free transport to blood donors as a recruitment tool during the COVID pandemic. (Zita Tobin) |
16h45-17h00 | Structure and data driving continuous improvement in IT service delivery. (Jacques Breslaw) | An analysis of donor collection labelling errors following a quality improvement project. (Antoinette Porter) | Attitude and perceptions of blood donors of the Western Cape Blood Service towards sample donation for biobanking. (Adrian Brink) |
17h00-17h15 | Business intelligence drive to enable data driven decision making for the effective implementation of the COVID-19 workplace plan and risk management. (Mandy Jamieson) | Haematological reference ranges in blood donors served by the National Blood Service Zimbabwe, Harare branch. (Menard Mutenherwa) |
The impact of COVID-19 on the Western Cape Blood Service donor base. (Michelle Vermeulen) |
17h15-17h30 | Predicting deferral due to low haemoglobin – the Sanguinstats Collaboration. (Ronel Swanevelder) |
Implementation of a risk-based quality notification system reduced the number of notification-associated disciplinary actions. (Leesha Raman) |
|
17h15-17h45 | Buses return to SS Elangeni | ||
18h45-19h15 | Buses depart from hotel to Durban ICC | ||
19h00-23h00 | Casual Dinner & Singing Competition (Hall 1, Durban ICC) Theme: Mzanzi’s Got Talent! |
||
22h30-23h00 | Buses return to hotel (staggered departure) |
GREAT ILANGA | ILANGA SUITE 1-3 | ILANGA SUITE 4-5 | |
06h00-07h00 | Beach clean-up (meet on the promenade opposite the SS Elangeni) | ||
08h30-17h00 | Registration open | ||
08h15-08h45 | Buses depart for Durban ICC from SS Elangeni | ||
09h00-10h30 | PLENARY 3 Hall 1 (Chairs: Karin van den Berg & Vernon Louw) |
||
09h00-09h30 | Plasma donor health and vigilance (an overview of potential consequences of plasma donation). (Christian Erikstrup) |
||
09h30-10h00 | Safety and security of supply in blood transfusion: using risk-based decision making to inform our choices and guide our actions. (Graham Sher) |
||
10h00-10h30 | Ethics debate – mandatory COVID vaccination. (Melodie Labuschaigne vs Mark Sonderup) |
||
10h30-11h00 | Tea break | ||
11h00-12h30 | Plasma and PDMPs Room 11 (Chairs: Jeh-Han Omarjee & Willem van der Merwe) |
Safe and sufficient blood donation Room 21 (Chairs: Siemi Prithvi Raj & Michelle Vermeulen) |
|
11h00-11h30 | Access to plasma-derived medicinal products in resource-constrained countries. (Thierry Burnouf) |
Motivations for blood donation by HIV-positive individuals on antiretrovirals in South Africa: a qualitative study. (Karin van den Berg) |
|
11h30-12h00 | The role of hyperimmune plasma. (Jeh-Han Omarjee) |
#IRONSTRONG: Implementing an iron management program amongst whole blood donors at the South African National Blood Service. (Pheello Lethola) |
|
12h00-12h15 | A retrospective analysis of apheresis services in Zimbabwe from 2017-2021. (Miriam Zuze) |
The impact of the smart redirect SMS in encouraging youth blood donations at non-academic blood drives during the lockdown. (Alanna Shingirai Kondo) | |
12h15-12h30 | Plasmapheresis in resources limited areas: experience from Namibia. (Judith Sinvula) | Advances in HIV and viral hepatitis residual transfusion transmission risk estimation. (Eduard Grebe) |
|
12h30-14h00 | Lunch Break (Exhibition Hall 2) | ||
14h00-15h30 | Insights into transfusion-transmissible infections Room 21 (Chairs: Carmen Addinall & Charl Coleman) |
Clinical transfusion practice Room 11 (Chairs: Karin van den Berg & Solomuzi Ngcobo) |
Finance, logistics and HR Room 12 (Chairs: Josephine Mitchel & Ashleigh Button) |
14h00-14h30 | Update on viral hepatitis in South Africa. (Mark Sonderup) |
Future proofing transfusion services: a decision support model for blood usage in South Africa. (Larisse Bolton) |
Capacity development in transfusion medicine research (Fogarty South Africa program). (Ed Murphy) |
14h30-14h45 | Seroprevalence of transfusion transmittable infections: HIV, Hepatitis B, C and treponema pallidum and associated factors among blood donors in Ethiopia. (Abiy Sisay) |
Red cell concentrate usage in South Africa in 2019 – is the usage driven by access to healthcare? (Solomuzi Ngcobo) |
A case study on the impact of change management in the SANBS KZN campus move. (Alison Visagie) |
14h45-15h00 | The impact of early antiretroviral treatment for HIV on the sensitivity of the latest generation of blood screening and point of care assay. (Marion Vermeulen) |
A retrospective study on the blood components transfused and clinical conditions that led to the transfusion at Parirenyatwa Group of Hospitals from January 2018 to December 2018. (Brian Mukarati) |
Ensuring sustainable funding of blood services in low and medium income countries through cost recovery alone: experience from Namibia. (Christina J. Gouws) |
15h00-15h15 | Investigation of the impact of universal HBV vaccination on young blood donors in South Africa. (Wendy Sykes) |
The verbal abuse against South African National Blood Service laboratory personnel – a scourge that should not be allowed to happen. (Solomuzi Ngcobo) | Investigating the effectiveness of the current talent management practices on staff engagement nationwide within the South African National Blood Services. (Reynier Willemse) |
15h15-15h30 | Hepatitis E prevalence amongst blood donors in South Africa. (Charl Coleman) |
Comparing the degree of red cell haemolysis, including blood volume yielded, between two techniques of extracting blood from surgical swabs. (Kerissa Moodley) |
Promoting emotional well-being and physical activity while working from home. (Lerato Mautlane) |
15h30-16h00 | Tea break (Exhibition Hall 2) | ||
16h00-17h30 | Safer transfusion practice Room 11 (Chairs: Ute Jentsch & Riana Cockeran) |
Blood donor retention Room 21 (Chairs: Siemi Prithvi Raj & Alanna Kondo) |
Capacity building and training Room 12 (Chairs: Michele Breuninger & Wendy Sykes) |
16h00-16h15 | Virus inactivation technologies of blood products. (Thierry Burnouf) |
Haemochromatosis and the role of the blood services in therapeutic venesection. (Mark Sonderup) |
Transfusion medicine and blood banking education and training for blood establishment laboratory staff: a review of selected countries in Africa. (Vanitha Rambiritch) |
16h15-16h30 | Broadening blood transfusion knowledge through emerging technologies. (Mveli Manyatsi) |
||
16h30-16h45 | Evaluation of amotosalen and UVA-pathogen reduced platelets after 7-day storage. (Richard Benjamin) |
The effectiveness of the WCBS blood donor milestone programme. (Marike Gevers) | Research training for HIV-related haematology and blood transfusion research in South Africa. (Edward Murphy) |
16h45-17h00 | Introduction of IgG-specific anti-A and anti-B titrations in the red cell serology laboratory. (Moses Moloi) |
Blood collection & donor recruitment during the COVID-19 pandemic in the Mpumalanga zone. (Msimelelo Lose) | The SANBS lookback programme: exploring internal stakeholders’ awareness of the programme. (Amanda Xaba) |
17h00-17h15 | The impact of introduction of the electronic crossmatch in SANBS Blood Banks. (Itumeleng Phayane) |
The effectiveness of partnerships with Muslim community-based organisations to increase blood collections during low collection periods. (Aishah Salie) | The future of technical training – a showcase of video based technical training. (Neal Joshua) |
17h15-17h30 | Platelet safety and utilization in France before and after the transition to 100% pathogen reduced platelets and 7-day storage for platelet components as the national standard of care. (Richard Benjamin) |
Standardisation of blood donation clinic workflows at the Western Cape Blood Service. (Sybil Marcel Jacobs) |
A critical review of the law and policy framework in dealing with gender-based violence in South Africa – are there implementation gaps? (Solomuzi Ngcobo) |
17h30-17h45 | Buses return to SS Elangeni | ||
18h45-19h15 | Buses depart from hotel to Durban ICC | ||
19h00-23h00 | Gala Dinner (Hall 1, Durban ICC) Theme: A sustainable future Dress code – Semi-formal with a touch of red, green and/or gold to show your passion for saving lives, sustainability and a sparkle for the future. |
||
22h30-23h00 | Buses return to hotel (staggered departure) |
08h00-17h00 | Registration open |
08h15-08h45 | Buses depart for Durban ICC from SS Elangeni |
09h00-10h30 | PLENARY 4 Hall 1 (Chairs: Greg Bellairs & Russell Cable) |
09h00-09h30 | The POPI Act in the health care context: legal position. (Melodie Labuschaigne) |
09h30-10h00 | Ethical considerations in the management of anaemia in pregnancy. (Vernon Louw) |
10h00-10h30 | HTLV and transfusion risk update. (Edward Murphy) |
10h30-11h00 | Tea break |
11h00-12h30 | PLENARY 5 – CLOSING SESSION Hall 1 (Chairs: Pheello Lethola & Marion Vermeulen) |
11h00-11h25 | Measuring population immunity and identifying serological correlates of protection against SARS-CoV-2 infection using repeat blood donor cohorts. (Eduard Grebe) |
11h25-11h50 | SARS-CoV-2 infection-and vaccine-induced seroprevalence studies in blood donors. (Mars Stone) |
11h50-12h15 | Looking back to look forward: what lessons from the last three decades in blood transfusion best inform how we build sustainability over the next three? (Graham Sher) |
12h15-12h30 | Closing (Wendy Sykes) |
12h30-13h00 | Grab ‘n go lunch |